AUPH
Aurinia Pharmaceuticals Inc
16.70$
+0.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.5% | -26.4% | +142.8% | +10.2% | -31.3% | +15,660.4% | -9.0% | +193.9% | +31.0% | +34.0% | +20.4% | |
| – | -67.6% | -66.7% | -75.0% | +4,138,100.0% | +27.8% | -4.8% | -97.8% | +419.2% | +149.8% | +99.7% | +15.6% | |
| – | -7.5% | -24.2% | +147.9% | -9,865.9% | – | +15,660.4% | -11.2% | +188.4% | +25.7% | +28.2% | +21.0% | |
| – | +75.4% | -9.1% | +133.5% | +22.0% | +27.8% | -4.8% | +1.6% | -12.0% | +10.3% | -58.1% | +56.4% | |
| – | -9.1% | +11.3% | +73.5% | +13.0% | +63.4% | +335.5% | +76.2% | +14.5% | -0.7% | -19.0% | -37.6% | |
| – | +35.8% | -3.4% | +106.6% | +19.2% | +61.2% | +69.2% | +45.9% | +6.5% | +5.5% | -16.4% | -31.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +66.7% | -46.0% | +2,500.0% | +218.2% | -98.3% | +13,471.8% | -90.0% | +867.5% | -45.8% | +74.2% | -10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | +1,432.7% | |
| – | -16,676.7% | – | +4,873.8% | -99.7% | +97.3% | -165.3% | – | +140.5% | -69.9% | +207.8% | -10,303.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +4,893.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +302.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.